Day: September 29, 2023

OTTAWA, Sept. 29, 2023 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions has announced the addition of a Digital Health portfolio to its existing Health Solutions division. Calian’s Digital Health division was established to better capture opportunities across the evolving healthcare landscape and to better serve Calian’s growing client-base. The Digital Health portfolio delivers services and award-winning software applications which improve access to high-quality care, while transforming the patient and care provider experience. “For more than 13 years, we’ve delivered world-class healthcare solutions to clients across Canada,” says Kevin Ford, Calian CEO. “Our digital solutions create seamless connections...

VANCOUVER, British Columbia, Sept. 29, 2023 (GLOBE NEWSWIRE) — New Pacific Metals Corp. (TSX: NUAG; NYSE American: NEWP) (“New Pacific” or the “Company”) announced today that it has closed (the “Closing“) the bought deal financing that was previously announced on September 25, 2023. A total of 13,208,000 common shares of the Company (the “Offered Shares”) were sold under the Offering (as defined below) at a price of C$2.65 per Offered Share (the “Issue Price”) for total gross proceeds of approximately C$35 million (the “Offering”). The Offering was through a syndicate of underwriters (the “Underwriters”), pursuant to the terms of an underwriting agreement between the Company and the Underwriters dated September 26, 2023 (the “Underwriting Agreement“). Silvercorp Metals Inc. (“Silvercorp”) participated in...

Not for Distribution in the United States or to U.S. Newswire Services VANCOUVER, British Columbia, Sept. 29, 2023 (GLOBE NEWSWIRE) — New Pacific Metals Corp. (TSX: NUAG; NYSE American: NEWP) (“New Pacific” or the “Company”) announced today that it has closed (the “Closing“) the bought deal financing that was previously announced on September 25, 2023. A total of 13,208,000 common shares of the Company (the “Offered Shares”) were sold under the Offering (as defined below) at a price of C$2.65 per Offered Share (the “Issue Price”) for total gross proceeds of approximately C$35 million (the “Offering”). The Offering was co-led by Raymond James Ltd. and Eight Capital (together, the “Co-Lead Underwriters”), on behalf of a syndicate of underwriters (collectively with the Co-Lead Underwriters, the “Underwriters”), pursuant...

WESTPORT, Conn., Sept. 29, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as single agents and in combination, today announced that it has entered into a definitive agreement for the purchase and sale in a registered direct offering of an aggregate of 3,157,895 shares of its common stock (or common stock equivalents in lieu thereof), at a purchase price of $1.90 per share (or common stock equivalent in lieu thereof). The Company has also agreed to issue in a concurrent private placement unregistered series A warrants to purchase up to an aggregate of 3,157,895 shares of common stock, series B warrants to purchase up to an aggregate of 3,157,895 shares of common stock and series C warrants to purchase up to an aggregate of 3,157,895...

Transformative nine-year contract enhances well intervention and exploration logging services for Vår Energi Second order includes advanced subsea production systems Two contracts with Vår Energi significantly reinforce Baker Hughes’ industry leadership and growth trajectory HOUSTON and LONDON, Sept. 29, 2023 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR), an energy technology company, announced Friday two awards from Vår Energi that expand its regional presence in the North Sea for exploration logging, well intervention technology and subsea production systems. The first contract, a nine-year engagement, is a testament to Baker Hughes’ heightened well intervention capabilities gained through the strategic acquisition of Altus Intervention completed in April 2023. In addition to the interventions scope, Baker Hughes will supply...

If approved, odronextamab would be the first and only bispecific antibody approved in both FL and DLBCL – the two most common subtypes of non-Hodgkin lymphoma European Medicines Agency also reviewing odronextamab Marketing Authorization Application TARRYTOWN, N.Y., Sept. 29, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for odronextamab to treat adult patients with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), who have progressed after at least two prior systemic therapies. The target action date for the FDA decision is March 31, 2024. Odronextamab is an investigational CD20xCD3 bispecific antibody designed to bridge...

Dovre Group Plc                            Press release                 September 29, 2023, at 3.30 pm Dovre Group´s Norwegian operations, i.e. Dovre Group Energy and Dovre Group Consulting, have been attacked by ransom virus at one of our servers in Stavanger We are working closely together with our IT-partner on our contingency plan and are already up and running on safe email and basic office systems. The server involved contains part of our financial systems and operational directories. The impact for our consultants and clients is limited as the majority of our consultants in Norway are working within our clients´ organization, using their IT-systems. Our main challenge is that our internal administration will have an extra burden in the coming period.   It is too early to estimate further economic consequences, focus now is to secure...